Patrolling Monocytes in Sickle Pain Crisis and following Transfusion Abstract Patients with sickle cell disease (SCD) suffer from intravascular hemolysis associated with vascular injury and dysfunction. Painful vaso-occlusive crisis (VOC) involving increased attachment of sickle erythrocytes and activated leukocytes to damaged vascular endothelium is also a hallmark of SCD. Transfusion lowers sickle (hemoglobin (Hb S)-containing) RBCs mass, although its use for VOC remains controversial. In SCD, patrolling monocytes, which normally scavenge damaged cells and debris from the vasculature, express higher levels of anti-inflammatory heme oxygenase 1 (HO-1), a heme degrading enzyme with anti-cytotoxic and anti- inflammatory properties. We have found that patients with SCD have a novel subset of patrolling monocytes expressing very high levels of HO-1 (HO-1hi) which are decreased in numbers in patients who had a recent VOC episode. This monocyte subset was responsible for uptake of hemolysis-damaged endothelium as well as SCD, but not HD RBCs. In mice, increasing their numbers lowered adherent SCD RBC attachment to the hemolysis-damaged vascular endothelium. In this proposal, we will test the hypothesis that SCD patrolling monocytes scavenge and remove damaged endothelium and endothelial-attached sickle RBCs, resulting in HO-1 upregulation and dampening of VOC. We postulate that when HO-1hi patrolling monocytes are limiting, there is a buildup of vascular damage and increased sickle RBC attachment to the endothelium, which in turn increases the risk of VOC. We further posit that transfusions improve survival of HO-1hi patrolling monocytes, enabling them to effectively clear the vasculature from damaged endothelial cells, thereby affording protection against VOC. To test our hypotheses, we will determine the mechanisms by which patrolling monocytes protect SCD vasculature (aim 1);
in aim 2, we will dissect the role of HO-1 in anti-VOC activity of patrolling monocytes, and finally in aim 3, we will examine the association of patrolling monocytes and HO-1hi subset during i) acute VOC and ii) with chronic transfusions. Altogether, we believe that these studies will help establish the role of HO-1hi patrolling monocytes in VOC pathophysiology, and their potential as a therapeutic target for VOC.

Public Health Relevance

Patrolling Monocytes in Sickle Pain Crisis and following Transfusion Patients with sickle cell disease suffer from obstructed blood vessels by sticky sickle red cells, causing the patient to have devastatingly painful episodes, called crises. Our studies have identified certain white blood cells, called patrolling monocytes, which clear the blood vessels from damaged cells caused by hemolysis and protect against pain crisis. In this proposal, we will determine if transfusions can bolster these patrolling monocytes and whether we can use these patrolling monocytes to pre-screen patients at risk of painful crisis and more importantly as a cure for painful crisis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL145451-02
Application #
9976576
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Zou, Shimian
Project Start
2019-07-15
Project End
2023-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Name
New York Blood Center
Department
Type
DUNS #
073271827
City
New York
State
NY
Country
United States
Zip Code
10065